Femasys Inc. (FEMY) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$5.07M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$4.22M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$3.65M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$3.85M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -$5.07M | (m) | $331.83K | (m) | $9.40K* | -$3.94M* | $142.44K | $1.95M | (m) | $865.00 |
| 2026-03-31 | Reported | (m) | -$4.22M | (m) | $424.89K | (m) | $79.14K | -$4.14M | $158.61K | $1.31M | (m) | $0.00 |
| 2025-09-30 | Reported | (m) | -$3.65M | (m) | $729.39K | (m) | $194.33K* | -$5.39M* | $293.84K | $1.38M | (m) | $0.00 |
| 2025-06-30 | Reported | (m) | -$3.85M | (m) | $409.27K | (m) | $94.23K* | -$4.35M* | $158.17K | $1.41M | (m) | $0.00 |
| 2025-03-31 | Reported | (m) | -$5.46M | (m) | $341.26K | (m) | $96.61K | -$4.77M | $117.27K | $2.97M | (m) | -$4.19K |
| 2024-09-30 | Reported | (m) | -$5.12M | (m) | $554.91K | (m) | $407.94K* | -$5.47M* | $190.84K | $2.30M | (m) | $1.16K |
| 2024-06-30 | Reported | (m) | -$4.48M | (m) | $221.48K | (m) | $182.42K* | -$4.33M* | $73.13K | $1.98M | (m) | -$1.75K |
| 2024-03-31 | Reported | (m) | -$3.46M | (m) | $271.14K | (m) | $64.56K | -$4.57M | $88.53K | $1.77M | (m) | $0.00 |
| 2023-09-30 | Reported | (m) | -$4.08M | (m) | $244.36K | (m) | $27.17K* | -$2.86M* | $86.19K | $2.07M | (m) | $0.00 |
| 2023-06-30 | Reported | (m) | -$2.94M | (m) | $320.51K | (m) | $62.95K* | -$2.74M* | $110.47K | $1.53M | (m) | $0.00 |
| 2023-03-31 | Reported | (m) | -$3.04M | (m) | $293.98K | (m) | $8.90K | -$2.65M | $105.12K | $1.54M | (m) | (m) |
| 2022-09-30 | Reported | (m) | -$3.06M | (m) | $347.46K | (m) | $18.54K* | -$2.73M* | $131.45K | $1.65M | (m) | (m) |
| 2022-06-30 | Reported | (m) | -$2.66M | (m) | $303.11K | (m) | $174.69K* | -$2.38M* | $102.35K | $1.47M | (m) | (m) |
| 2022-03-31 | Reported | (m) | -$2.88M | (m) | $321.40K | (m) | $120.37K | -$2.75M | $122.67K | $1.42M | (m) | (m) |
| 2021-09-30 | Reported | (m) | -$2.25M | (m) | $269.58K | (m) | $175.73K* | -$1.80M* | $105.40K | $1.14M | (m) | $0.00 |
| 2021-06-30 | Reported | (m) | -$1.90M | (m) | $326.01K | (m) | $12.51K* | -$2.72M* | $107.63K | $894.87K | (m) | $0.00 |
| 2021-03-31 | Reported | (m) | -$1.83M | (m) | $329.77K | (m) | $0.00 | -$1.16M | $93.04K | $995.02K | (m) | (m) |
| 2020-09-30 | Reported | (m) | -$1.56M | (m) | $313.21K | (m) | $3.30K* | -$859.02K* | $90.44K | $995.62K | (m) | $0.00 |
| 2020-06-30 | Reported | (m) | -$1.48M | (m) | $183.23K | (m) | (m) | (m) | $55.27K | $888.70K | (m) | $0.00 |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | -$17.59M | (m) | $2.29M | (m) | $525.01K | -$18.69M | $872.40K | $7.58M | (m) | $1.30K |
| 2024-12-31 | Reported | (m) | -$17.79M | (m) | $1.63M | (m) | $761.71K | -$19.44M | $544.90K | $8.22M | (m) | $9.60K |
| 2023-12-31 | Reported | (m) | -$14.51M | (m) | $1.07M | (m) | $143.92K | -$11.28M | $380.07K | $7.21M | (m) | $4.34K |
| 2022-12-31 | Reported | (m) | -$11.60M | (m) | $1.21M | (m) | $407.48K | -$10.73M | $441.94K | $5.81M | (m) | $6.30K |
| 2021-12-31 | Reported | (m) | -$8.34M | (m) | $1.18M | (m) | $306.87K | -$7.93M | $370.38K | $4.08M | (m) | $4.00K |
| 2020-12-31 | Reported | (m) | -$6.93M | (m) | $1.04M | (m) | $8.35K | -$4.93M | $306.53K | $4.13M | (m) | $1.80K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |